Pfizer

Forbes | April 21, 2016

Scientists are super-excited about the way cheap, fast DNA sequencing technology is making it possible to gather vivid, detailed information about the microbiome. These are the trillions of bugs in our guts, and on our skin, that humans have co-existed with since the beginning. Drug companies, until fairly recently, haven’t been that interested, or at least haven’t seen clear ways the science can applied with new drugs. But that’s changing. Today, a little company in South San ...

| April 28, 2016

Drug companies Wyeth and Pfizer have agreed to pay $784.6 million to settle allegations that Wyeth did not provide the same drug discounts to Medicaid that it gave to private buyers, the U.S. Attorney's office announced Wednesday. As part of the settlement, Wyeth and Pfizer do not deny the government's allegations. Pfizer, which is headquartered in New York City, bought Wyeth in 2009. The actions in question occurred before the acquisition....

dnaindia | May 16, 2016

Drug major Pfizer Inc on Monday said it will acquire biopharmaceutical firm Anacor Pharmaceuticals for around $5.2 billion in an all-cash deal. Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of approximately $5.2 billion, Pfizer Inc said in a statement....

Healthcare Finance | December 19, 2018

Pharma giants Pfizer and GlaxoSmithKline are creating a joint venture consumer healthcare business. The Boards of Directors of both companies have unanimously approved the transaction under which Pfizer's consumer healthcare business will essentially roll into GlaxoSmithKline's existing consumer healthcare business. It will operate globally under the GSK Consumer Healthcare name. Pfizer will own less than 50 percent of the joint venture and GSK Consumer Healthcare expects to deconsolidat...